🇺🇸 FDA
Pipeline program

Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets

CSET 2025/4132

Phase 3 small_molecule active

Quick answer

Vidaza 25 mg/ml powder for suspension for injection, Venclyxto 100 mg film-coated tablets for Acute Myeloid Leukemia, ONCOLOGY is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Acute Myeloid Leukemia, ONCOLOGY
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials